Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

6 results
Display

A Case of Medullary Thyroid Carcinoma with de novo V804M RET Germline Mutation

Choi YS, Kwon HJ, Kim BK, Kwon SK, Park YH, Kim JH, Jung SB, Lee CH, Lee SK, Uchino S

Many cases of RET proto-oncogene mutations of hereditary medullary thyroid carcinoma (MTC) have been reported in Korea. However, MTC with V804M RET proto-oncogene germline mutations have not been reported in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Korean Family of Familial Medullary Thyroid Cancer with Cys618Ser RET Germline Mutation

Jung J, Uchino S, Lee Y, Park H

Familial medullary thyroid carcinoma (FMTC) is caused by autosomal dominant gain-of-function mutations in the RET proto-oncogene. An identifiable RET mutation can be detected in about 85% of FMTC families. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
RET Fusion Genes in Korean Non-Small Cell Lung Cancer

Yoo SS, Jin G, Jung HJ, Hong MJ, Choi JE, Jeon HS, Lee SY, Lim JO, Park JY

Recently, rearranged during transfection (RET) fusions have been identified in approximately 1% of non-small cell lung cancer (NSCLC). To know the prevalence of RET fusion genes in Korean NSCLCs, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of breast cancer in a patient with multiple endocrine neoplasia type 2

Roh JM, Lee YB, An HR, Shim WH, Lee EH, Hong SW, Cho MH

  • KMID: 2259348
  • Korean J Med.
  • 2010 Oct;79(4):432-437.
Multiple Endocrine Neoplasia Type 2 (MEN2) is a rare hereditary complex disorder characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, and other hyperplasias or neoplasias of different endocrine tissues...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells

Chang H, Sung JH, Moon SU, Kim HS, Kim JW, Lee JS

PURPOSE: Rearrangement of the proto-oncogene rearranged during transfection (RET) has been newly identified potential driver mutation in lung adenocarcinoma. Clinically available tyrosine kinase inhibitors (TKIs) target RET kinase activity, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut

Takaki M, Goto K, Kawahara I

  • KMID: 2381146
  • J Neurogastroenterol Motil.
  • 2014 Jan;20(1):17-30.
We explored a novel effect of 5-hydroxytryptamine 4 receptor (5-HT4R) agonists in vivo to reconstruct the enteric neural circuitry that mediates a fundamental distal gut reflex. The neural circuit insult...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr